MCHENRY, Ill., Aug. 6, 2019 /PRNewswire/ -- Today, Medela LLC today announced its support of Breastfeeding: Uncovered, a partnership between Medela and

Dr. Alan Korman, renowned for his work leading to the development the first approved checkpoint inhibitor cancer therapies, joins Dragonfly's scientific team. WALTHAM, Mass., Aug. 6, 2019 /PRNewswire/ -- Dragonfly Therapeutics, Inc. ("Dragonfly") today announced the addition of world-leading cancer immunotherapy pioneer

ANAHEIM, Calif., Aug. 6, 2019 /PRNewswire/ -- AACC 2019 – New blood tests may help healthcare providers identify if patients are sensitized to up to 11 different molecular allergen component proteins found in dogs, cats, or horses. The assays analyze sensitivity to specific proteins found in the skin, fur and saliva of these animals.ImmunoCAP Aller

ANAHEIM, Calif., Aug. 6, 2019 /PRNewswire/ -- AACC 2019 – Thermo Fisher Scientific has expanded its portfolio of analytical instruments for clinical diagnostic laboratories with the addition of three systems now listed as Class I medical devices with the United States Food and Drug Administration (U.S. FDA). The portfolio enables clinical diagnostic labor

ANAHEIM, Calif., Aug. 6, 2019 /PRNewswire/ -- AACC 2019 – A new benchtop automated reading and incubation system for antimicrobial susceptibility testing (AST) provides microbiology laboratories with the accurate MIC results that clinicians need to confidently select an effective antibiotic for critically-ill patients while safeguarding future patient car

ANAHEIM, Calif., Aug. 6, 2019 /PRNewswire/ -- AACC 2019 – The launch of a robust, easy-to-handle, sustainable plate design for prepared culture media products in the U.S. and Canada supports the latest automated and manual methods for the analysis of microbiological samples for clinical, food safety testing and pharmaceutical

SOUTH JORDAN, Utah, Aug. 6, 2019 /PRNewswire/ -- Cianna Medical, powered by Merit Medical, has been named a "Top 10 Oncology Solution Provider" by Healthcare Tech Outlook, an innovation-focused healthcare publication for health system decision-makers.

CAMBRIDGE, Mass., Aug. 6, 2019 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy,  today announced that Andy Boral, M.D., Ph.D., Blueprint Medicines' Chief Medical Officer, will present a company overview a

YOKNEAM, Israel, Aug. 6, 2019 /PRNewswire/ -- SofWave Medical Ltd., an Israeli based aesthetic medical company developing Non-Invasive Fractional Ultrasound Technology for skin tightening, announced the closure of a $8.4M financing round.  The financing round was led by XT Hi-Tech and Dr. Shimon Eckhouse

LOVELAND, Colo., Aug. 6, 2019 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty healthcare products, today reported financial results for its second quarter ended June 30, 2019. The Company reports results in two segments: Core Companion Animal (